Gerlie Gieser

615 citations
4 papers · 463 indexed · 1 hit paper · h-index 4
Topics
Organ Transplantation Techniques and Outcomes (1 paper)Acute Myeloid Leukemia Research (1 paper)Lung Cancer Research Studies (1 paper)
Partner nations
United States

In The Last Decade

Gerlie Gieser

4 papers receiving 455 citations

Hit Papers

FDA Approval Summary: (Daunorubicin and Cytarabine) Lipos...2018202620202023201850100150200250

Peers

Gerlie Gieser
Comparison fields: 5 of 85
  • Molecular Biology 152
  • Biomaterials 114
  • Oncology 100
  • Biomedical Engineering 90
  • Pediatrics, Perinatology and Child Health 82
Replace Jan A. Lieverst with:
Jan A. Lieverst Netherlands
Lauren Price United States
EJ Estlin United Kingdom
Ruben A.G. van Eerden Netherlands
James J. Beaudoin United States
Jeroen S. Kloover Netherlands
Melanie Griffin United Kingdom
S. Murray Yule United Kingdom
Joshua Prey United States
JHM Schellens Netherlands
Gerlie Gieser relative to Jan A. Lieverst Netherlands Jan A. Lieverst's profile →
Citations per field
00.5×4.4×
Jan A. Lieverst · 1×
Citations per year

Countries citing papers authored by Gerlie Gieser

Since Specialization
Citations

This map shows the geographic impact of Gerlie Gieser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerlie Gieser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerlie Gieser more than expected).

Fields of papers citing papers by Gerlie Gieser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerlie Gieser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerlie Gieser. The network helps show where Gerlie Gieser may publish in the future.

Co-authorship network of co-authors of Gerlie Gieser

This figure shows the co-authorship network connecting the top 25 collaborators of Gerlie Gieser. A scholar is included among the top collaborators of Gerlie Gieser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerlie Gieser. Gerlie Gieser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
#WorkIndexed citations
1
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemiabreakdown →
252
2 88
3 9
4 114

About Gerlie Gieser

Gerlie Gieser is a scholar working on Transplantation, Pediatrics, Perinatology and Child Health and Genetics, having authored 4 papers that have together received 463 indexed citations. Recurring topics across this work include Organ Transplantation Techniques and Outcomes (1 paper), Acute Myeloid Leukemia Research (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Biomaterials (114 citations), Hematology (69 citations) and Pediatrics, Perinatology and Child Health (82 citations). Gerlie Gieser has collaborated with scholars based in United States. Frequent co-authors include Stacy S. Shord, Gideon M. Blumenthal, Richard Pazdur, Yuan Li Shen, Liang Li, Paresma Patel, Anamitro Banerjee, Jiang Liu, Xin Gao and Christopher M. Sheth. Their work appears in journals such as PEDIATRICS, Clinical Cancer Research and Clinical Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026